Julie R Park

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Cerebrospinal Fluid

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Anurekha G Hall, Devan M Duenas, Jenna Voutsinas, Qian Wu, Adam J Lamble, Elizabeth Gruber, Benjamin Wilfond, Julie R Park, Anurag K Agrawal, Jonathan M Marron
Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study. JNCI cancer spectrum 8 (4) (2024)
Colleen Annesley, Adam J Lamble, Corinne Summers, Michael A Pulsipher, Alan S Wayne, Julie Rivers, Wenjun Huang, Ashley Wilson, Qian Wu, Kristy D Seidel, Stephanie Mgebroff, Christopher T Brown, Catherine Lindgren, Julie R Park, Michael C Jensen, Rebecca A Gardner
Feasibility and Favorable Responses Following Investigational CAR T-Cell Therapy for Relapsed and Refractory Infant ALL. Blood advances (2024)
Navin R Pinto, Catherine M Albert, Mallory R Taylor, Heidi B Ullom, Ashley Lauren Wilson, Wenjun Huang, Jason P Wendler, Sowmya Pattabhi, Kristy Seidel, Christopher Brown, Joshua A Gustafson, Stephanie D Rawlings-Rhea, Safia H E Cheeney, Katelyn Burleigh, Heather H Gustafson, Rimas J Orentas, Nicholas A Vitanza, Rebecca A Gardner, Michael C Jensen, Julie R Park
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Anurekha G Hall, Devan M Duenas, Jenna Voutsinas, Qian Wu, Adam J Lamble, Elizabeth Gruber, Benjamin Wilfond, Julie R Park, Anurag K Agrawal, Jonathan M Marron
Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study. JNCI cancer spectrum 8 (4) (2024)
Jasia Mahdi, Jorg Dietrich, Karin Straathof, Claire Roddie, Brian J Scott, Tom Belle Davidson, Laura M Prolo, Tracy T Batchelor, Cynthia J Campen, Kara L Davis, Juliane Gust, Michael Lim, Robbie G Majzner, Julie R Park, Sonia Partap, Sneha Ramakrishna, Rebecca Richards, Liora Schultz, Nicholas A Vitanza, Leo David Wang, Crystal L Mackall, Michelle Monje
Tumor inflammation-associated neurotoxicity. Nature medicine (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ami Vijay Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak, Arlene Naranjo, Wendy B London, Sheena C Tenney, Mitchell B Diccianni, Jacquelyn A Hank, Marguerite T Parisi, Barry L Shulkin, Malcolm A Smith, Jeffrey A Moscow, Hiroyuki Shimada, Katherine K Matthay, Susan L Cohn, John M Maris, Rochelle Bagatell, Paul M Sondel, Julie R Park, Alice Lin-Tsing Yu
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Francesco Ceppi, Ashley Lauren Wilson, Colleen Annesley, Gabriella R Kimmerly, Corinne Summers, Adam Brand, Kristy Seidel, Qian Vicky Wu, Adam Beebe, Christopher Brown, Stephanie Mgebroff, Catherine Lindgren, Stephanie D Rawlings-Rhea, Wenjun Huang, Michael A Pulsipher, Alan S Wayne, Julie R Park, Michael C Jensen, Rebecca A Gardner
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects. Cancer immunology research 10 (7) (2022)
Nicholas A Vitanza, Ashley Lauren Wilson, Wenjun Huang, Kristy Seidel, Christopher Brown, Joshua A Gustafson, Jason K Yokoyama, Adam J Johnson, Blake A Baxter, Ryan W Koning, Aquene N Reid, Michael Meechan, Matthew C Biery, Carrie Myers, Stephanie D Rawlings-Rhea, Catherine M Albert, Samuel R Browd, Jason Scott Hauptman, Amy Lee, Jeffrey G Ojemann, Michael E Berens, Matthew D Dun, Jessica B Foster, Erin E Crotty, Sarah E S Leary, Bonnie L Cole, Francisco A Perez, Jason N Wright, Rimas J Orentas, Tony Chour, Evan William Newell, Jeffrey R Whiteaker, Lei Zhao, Amanda G Paulovich, Navin R Pinto, Juliane Gust, Rebecca A Gardner, Michael C Jensen, Julie R Park
Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety. Cancer discovery (2022)
Julie R Park, Judith G Villablanca, Barbara Hero, Brian H Kushner, Keith Wheatley, Klaus H Beiske, Ruth L Ladenstein, Sylvain Baruchel, Margaret E Macy, Lucas Moreno, Nita L Seibel, Andrew D Pearson, Katherine K Matthay, Dominique Valteau-Couanet
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer 128 (21) (2022)
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, Susan L Cohn, Wendy B London, Julie M Gastier-Foster, Nilsa C Ramirez, Ruthann Pfau, Shalini Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M Maris, Rochelle Bagatell, Julie R Park, Michael D Hogarty
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Nicholas A Vitanza, Adam J Johnson, Ashley L Wilson, Christopher Brown, Jason K Yokoyama, Annette Künkele, Cindy A Chang, Stephanie Rawlings-Rhea, Wenjun Huang, Kristy Seidel, Catherine M Albert, Navin R Pinto, Juliane Gust, Laura S Finn, Jeffrey G Ojemann, Jason Wright, Rimas J Orentas, Michael Baldwin, Rebecca A Gardner, Michael C Jensen, Julie R Park
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis. Nature medicine 27 (9) (2021)
Steven G DuBois, Meaghan P Granger, Susan Groshen, Denice Tsao-Wei, Lingyun Ji, Anasheh Shamirian, Scarlett Czarnecki, Fariba Goodarzian, Rachel Berkovich, Hiroyuki Shimada, Judith G Villablanca, Kieuhoa T Vo, Navin R Pinto, Yael P Mosse, John M Maris, Suzanne Shusterman, Susan L Cohn, Kelly C Goldsmith, Brian D Weiss, Gregory A Yanik, Clare J Twist, Meredith S Irwin, Daphne A Haas-Kogan, Julie R Park, Araz Marachelian, Katherine K Matthay
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)